Increased EpCAM Expression in Malignant Insulinoma: Potential Clinical Implications

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-08-0916
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Clinicopathologic Implications of EpCAM and Sox2 Expression in Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Clinical Management of Malignant Insulinoma: A Single Institution’s Experience Over Three Decades

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2018English

EpCAM Expression in Normal, Non-Pathological Tissues

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Expression of EpCAM in Uveal Melanoma

Cancer Cell International
Cancer ResearchOncologyGenetics
2006English

The Expression of EpCAM in Extramammary Paget's Disease

Intractable and Rare Diseases Research
Medicine
2019English

Clinical Remission of an Inoperable Malignant Insulinoma by the Combination Treatment With Octreotide and Everolimus

Journal of General and Family Medicine
2019English

Expression and Clinical Implications of P53, P63, and P73 Protein in Malignant Tumor of the Parotid Gland

Turkish Journal of Medical Sciences
Medicine
2014English

Biology and Clinical Relevance of EpCAM

Cell Stress
2019English

Clinical Implications of Molecular Neuropathology and Biomarkers for Malignant Glioma

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy